https://tiefenbachergroup.com/2023/05/10/successful-approval-of-manufacturing-and-laboratory-facilities-by-saudi-food-and-drug-authority/
https://tiefenbachergroup.com/2023/03/14/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-the-antihistamine-bilastine-for-a-market-entry-as-over-the-counter-otc-medicine-in-germany/
https://tiefenbachergroup.com/2023/02/25/tiefenbacher-groups-manufacturing-sites-have-been-successfully-registered-by-the-united-arab-emirates-ministry-of-health/
https://tiefenbachergroup.com/2022/12/01/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-generic-version-of-the-psoriasis-medication-apremilast-in-canada/
https://tiefenbacher-api.com/2021/06/22/supply-of-controlled-substances/
https://tiefenbacher-api.com/2021/05/11/tiefenbacher-api-ingredients-offer-pitavastatine-calcium/
https://tiefenbachergroup.com/2021/04/15/tiefenbacher-api-ingredients-starts-to-offer-the-first-api-based-on-green-chemistry/
https://tiefenbacher-api.com/2021/03/01/tiefenbacher-api-ingredients-offer-gmp-certificated-natural-medicinal-cannabidiol-cbd-with-highest-purity-profile-in-the-market/
https://tiefenbacher-api.com/2021/02/23/tiefenbacher-api-ingredients-secures-the-supply-of-critical-drug-for-covid-19-patients-dexmedetomidine-hydrochloride/